High PD-L1 Expression on Tumor Cells Indicates Worse Overall Survival in Advanced Oral Squamous Cell Carcinomas of the Tongue and the Floor of the Mouth but Not in Other Oral Compartments

• Published in: Biomedicines 2021-09, Vol.9 (9), p.1132
• Main Authors: Adamski, Łukasz Jan, Starzyńska, Anna, Adamska, Paulina, Kunc, Michał, Sakowicz-Burkiewicz, Monika, Marvaso, Giulia, Alterio, Daniela, Korwat, Aleksandra, Jereczek-Fossa, Barbara Alicja, Pęksa, Rafał
• Format: Article
• Language: English
• Subjects: Apoptosis; Biopsy; Cancer therapies; Cell death; Chemotherapy; Fibroblasts; IL-33; Immune checkpoint; Immunotherapy; interleukin 33; Lymphocytes; Medical prognosis; Metastasis; Microenvironments; Monoclonal antibodies; Multivariate analysis; Oral carcinoma; Oral cavity; Oral squamous cell carcinoma; PD-L1; PD-L1 protein; prognosis; programmed cell death-ligand 1; Radiation; Statistical analysis; Tongue; Tumor cells; Tumor microenvironment; Tumor-infiltrating lymphocytes; Tumorigenesis; Tumors; Variables
• ISSN: 2227-9059; 2227-9059
• DOI: 10.3390/biomedicines9091132

The markers of the tumor microenvironment (TME) are promising prognostic and predictive factors in oral squamous cell carcinoma (OSCC). The current study aims to analyze the immunohistochemical expression of programmed cell death-ligand 1 (PD-L1) and interleukin-33 (IL-33) in a cohort of 95 chemonaïve OSCCs. PD-L1 and IL-33 were assessed separately in tumor cells (TCs) and tumor-infiltrating lymphocytes (TILs). High PD-L1 expression in TILs was associated with better overall survival (OS) in univariate analysis. Tumors localized in the floor of the oral cavity and tongue tended to have a lower percentage of PD-L1-positive TCs when compared to other locations. PD-L1 expression on TCs had no prognostic significance when the whole cohort was analyzed. However, along with the T descriptor (TNM 8 ), it was included in the multivariable model predicting death in carcinomas of the floor of the oral cavity and tongue (HR = 2.51, 95% CI = 1.97-5.28). In other locations, only nodal status was identified as an independent prognostic factor in multivariate analysis (HR = 0.24, 95% CI = 0.08-0.70). Expression of IL-33 had no impact on survival, but it was differently expressed in various locations. In conclusion, the prognostic significance of PD-L1 in oral cancer depends on the tumor site and type of cell expressing immune checkpoint receptor (TCs vs. TILs).